Is it actually growing, and how fast?
A middle-of-the-pack grower that's turning around. Earnings are outgrowing revenue, a sign of improving margins and operating leverage. Quality of growth is high even if the top line is moderate. The strongest point: after shrinking over the last 3 years, revenue is set to grow 8%/yr from here. The one thing to watch: the company is not profitable yet.
Is the market behind it right now?
A poor multi-year track record but a sharp recent rally. Momentum is turning up, yet the trend is young and unproven — it needs follow-through to confirm rather than fade. The strongest point: it's up 26% over the past year, but 14% below its 52-week high. The one thing to watch: the multi-year record is weak.
Are you paying a fair price for it?
A fairly-priced stock. A mix of reasonable multiples and yields without extreme cheapness. Can work in diversified value portfolios, but not a standout bargain. The strongest point: its forward P/E of 15x is 42% below its own 26x historical median P/E. The one thing to watch: free cash flow is negative.
Is the business high-quality and durable?
Business quality is a weak point here. Profitability and capital efficiency lag the market. Better suited to value or turnaround angles than to quality strategies. The strongest point: best on EBITDA margin at 29%, better than 70% of companies worldwide. The one thing to watch: free cash flow is negative.
How does this stock score across Bastion factors?
Billed annually at $249/year $348